<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0024">
 <label>24.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Sagiv-Barfi</surname>
   <given-names>I</given-names>
  </string-name>, 
  <string-name>
   <surname>Kohrt</surname>
   <given-names>HE</given-names>
  </string-name>, 
  <string-name>
   <surname>Czerwinski</surname>
   <given-names>DK</given-names>
  </string-name>, et al. 
  <article-title>Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK</article-title>. 
  <source>
   <italic toggle="yes">Proc Natl Acad Sci U S A</italic>
  </source>. 
  <year>2015</year>;
  <volume>112</volume>(
  <issue>9</issue>):
  <fpage>E966</fpage>â€“
  <lpage>E972</lpage>. doi:
  <pub-id pub-id-type="doi">10.1073/pnas.1500712112</pub-id>
  <pub-id pub-id-type="pmid">25730880</pub-id>
 </mixed-citation>
</ref>
